Comparing two surgical methods for correcting fetal myelomeningocele

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility of a fetoscopic surgical technique for the antenatal correction of fetal myelomeningocele, a type of neural tube defect. Participants will be assigned to one of two surgical approaches: a percutaneous method for those with a posterior placenta and a laparotomy/uterine exteriorization method for all participants regardless of placental location. The study aims to determine the effectiveness and safety of these interventions in improving outcomes for affected fetuses. The surgical techniques will be assessed based on their feasibility and potential benefits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Myelomeningocele (including myeloschisis) at level T1 through S1 with hindbrain herniation. Lesion level and hindbrain herniation will be confirmed by MRI and ultrasonography.
2. Maternal age ≥18 years.
3. Gestational age of 19 to 27 6/7 weeks' gestation as determined by clinical information and evaluation of first ultrasound.
4. Balanced karyotype with written confirmation of culture results. Results by fluorescence in situ hybridization (FISH) will be acceptable if the patient is at 24 weeks or more.
5. Positive evaluation of social work consult indicating the patient is capable of consenting to the procedure and has the appropriate social support system to participate in the study.
6. Positive evaluation from pediatric neurology consult.
7. Willing to remain in the greater Wellington or Pasadena area (within a 30-minute car ride) for remainder of the pregnancy and deliver at Wellington Regional Medical Center or Huntington Memorial Hospital for postnatal management. The participants must be willing to return to our center for the 12, 24, 30, 48, and 60 months for follow-up evaluation.

Exclusion Criteria:

1. Multiple gestation
2. Insulin-dependent pregestational diabetes
3. Presence of a fetal anomaly not related to myelomeningocele. A fetal echocardiogram will be conducted before surgery and if the finding is abnormal, the patient will be excluded.
4. Fetal kyphosis of 30 degrees or more, assessed by ultrasound or MRI.
5. Presence of uterine cervical cerclage or history of incompetent cervix.
6. Placenta previa or placental abruption.
7. Short cervix \< 25 mm measured by cervical ultrasound.
8. Obesity as defined by body mass index (BMI) of 35 or greater.
9. History of previous spontaneous singleton delivery prior to 37 weeks.
10. Maternal-fetal Rh isoimmunization, Kell sensitization or a history of neonatal alloimmune thrombocytopenia.
11. Maternal HIV or Hepatitis-B status positive because of the increased risk of transmission to the fetus during maternal-fetal surgery. If the patient's HIV or Hepatitis B status is unknown, the patient must be tested and found to have negative results before she can be enrolled.
12. Known Hepatitis-C positivity. If the patient's Hepatitis C status is unknown, she does not need to be screened.
13. Uterine anomaly such as large (greater than 6 cm) fibroids, cervical fibroids or multiple fibroids or Mullerian duct abnormality.
14. Other maternal medical condition which is a contraindication to surgery or anesthesia.
15. Patient does not have a support person (e.g., husband, partner, parents).
16. Inability to comply with the travel and follow-up requirements of the study.
17. Patient does not meet psychosocial criteria as determined by the social worker evaluation.
18. Participation in another intervention study that influences maternal and fetal morbidity and mortality.
19. Maternal hypertension as determined by the investigator, which would increase the risk of preeclampsia or preterm delivery (including, but not limited to: uncontrolled hypertension, chronic hypertension with end organ damage and new onset hypertension in current pregnancy).
20. Bicornuate uterus or any other uterine malformation the PI decides is not safe for surgery.
21. Nickel allergy.
22. Maternal request to undergo open fetal surgery for the antenatal correction of open spina bifida at our institution primarily or after failed fetoscopic approach.
23. Known maternal hypersensitivity to bovine collagen or chondroitin materials.

Where it's running

• University of Southern California / Huntington Memorial Hospital
  Los Angeles, California, United States Recruiting
• Wellington Regional Medical Center
  Wellington, Florida, United States Recruiting

Study contacts

• Principal investigator: Ruben Quintero, MD — Wellington Regional Medical Center
• Study coordinator: Ruben Quintero, MD
• Email: q@the-fetal-institute.com
• Phone: 720-753-3825

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• tSCS for improving leg strength and walking in kids with spina bifida

  This pilot test will try non-invasive transcutaneous spinal cord stimulation to see if it helps improve leg muscle strength and walking in children with myelomeningocele who can walk a little with help.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07615686

• Fetoscopic repair of neural tube defects

  This study looks at how well a special surgery done before birth can help babies with spina bifida and what happens to them after the procedure.

  Recruiting Oregon Health and Science University · Portland, Oregon · NCT06946563

• Transcutaneous spinal stimulation for children and teens with spina bifida

  This study will try gentle, non-invasive electrical stimulation of the spinal cord to see if it can strengthen legs and improve movement in children and teens with spina bifida.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT06918119

• Using cryopreserved human umbilical cord to repair spina bifida in fetuses

  This study is testing whether using preserved human umbilical cords can help repair spinal cord defects in fetuses with spina bifida to improve their health and development.

  Recruiting The University of Texas Health Science Center, Houston · Houston, Texas · NCT06042140

• Able Kids device: safer gait aid for kids with neurologic gait problems

  This study tests whether the ABLE Kids wearable exoskeleton can be safely used during a 10-session gait training program for children with neurological gait disorders or muscle weakness.

  Recruiting ABLE Human Motion S.L. · Girona, Girona · NCT07745712

• Bowel continence across life for people with spina bifida

  This project will test whether retrograde (through the anus) or antegrade (through a tube into the colon) enema programs work better to prevent bowel accidents and improve independence for people with spina bifida ages 5 and up who are starting or switching an enema program.

  Recruiting at 23 sites Ann & Robert H Lurie Children's Hospital of Chicago · Birmingham, Alabama and 23 other locations · NCT07390318

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.